Dysregulation of genetic and transcriptional mechanisms is linked to cellular pathogenesis, oncogenesis and malfunction. The experimental oncology group is searching for non-genetic tools for disease prediction and diagnostics and new targets to provide an effective therapeutic solution with science and technology conjunction: chemotherapy, radiobiology, and antitumor immunotherapy. The laboratory collaborates closely with the scientists of the Russian Academy of Sciences and the pharmaceutical industry in Russia and all over the world (South Carolina, Hong Kong, Finland, Japan) and develops advanced approaches in oncology.
